Table: Ono Pharm -2020/21 group results (IFRS)

ONO PHARMACEUTICAL

11/05/2021 04:00

May 11 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            309.28          292.42                                
                 (+5.8 pct)      (+1.3 pct)                              
  Sales                                           350.00                 
                                                (+13.2 pct)              
  Operating         98.33           77.49         105.00                 
                 (+26.9 pct)     (+25.0 pct)    (+6.8 pct)               
  Pretax           100.89           79.70         107.00                 
                 (+26.6 pct)     (+22.3 pct)    (+6.1 pct)               
  Net               75.43           59.70          83.00                 
                 (+26.3 pct)     (+15.8 pct)    (+10.0 pct)              
  EPS Basic      151.11 yen      118.47 yen     166.29 yen               
  EPS Diluted    151.09 yen      118.45 yen                              
  Ann Div         50.00 yen       45.00 yen      56.00 yen               
  -Q2 Div         22.50 yen       22.50 yen      28.00 yen               
  -Q4 Div         27.50 yen       22.50 yen      28.00 yen               
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T